We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Potential Drug Target for Diabetic Retinopathy

News   Sep 20, 2019 | Original story from Elsevier

 
A Potential Drug Target for Diabetic Retinopathy

ffect of recombinant lysyl oxidase propeptide (rLOX-PP) on the development of acellular capillaries (ACs) and pericyte loss (PL) in rat retinas. A-D: Representative retinal trypsin digest images showing retinal vascular networks of a control rat (A), diabetic (DM) rat (B), rat intravitreally injected with rLOX-PP (C), and rat intravitreally injected with phosphate-buffered saline (PBS) (D). LOX-PP administration promoted the development of ACs (arrows) and PL (arrowheads) associated with diabetic retinopathy. Enlarged images correspond to boxed areas (Right panels of A, B, C, D). Scale bar = 100 μm. Credit: The American Journal of Pathology

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

Targeted Therapy Could Help Children With Deadly Nerve Cancer

News

Mount Sinai researchers have discovered a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE